Globe Life (FRA:TMJ) Research & Development: €0 Mil (TTM As of Mar. 2026)


FRA:TMJ Globe Life Inc FRA:TMJ
85 GF Score
Price €153.50
GF Value €130.79
Valuation Modestly Overvalued
! 9 Warning Signs
View Full Analysis

What is Globe Life Research & Development?

Globe Life FRA:TMJ +2.47% 85 Research & Development is €0 Mil as of Mar. 2026. GuruFocus rates FRA:TMJ with a GF Score™ of 85/100 and a GF Value™ of €130.79 (Modestly Overvalued). The stock has 9 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Globe Life's Research & Development for the three months ended in Mar. 2026 was €0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was €0 Mil.

Globe Life  (FRA:TMJ) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Globe Life Research & Development Related Terms

Globe Life Research & Development Historical Data

* Premium members only.

The historical data trend for Globe Life's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Globe Life Research & Development Chart

Globe Life Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Globe Life Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
FRA:TMJ
85GF Score
Globe Life Inc FRA:TMJ
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Globe Life Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €0 Mil mean?
Globe Life (FRA:TMJ) has a Research & Development of €0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Globe Life and its competitors.
Is Globe Life's Research & Development too high?
Globe Life's current Research & Development is €0 Mil. Overall, Globe Life has a GF Score™ of 85/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Globe Life's Research & Development compare to UNM and PRI?
Globe Life's Research & Development of €0 Mil can be compared against companies in the Insurance industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for an Insurance company?
A good Research & Development depends on the Insurance industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Globe Life and its competitors. Globe Life's current Research & Development is €0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Globe Life stock overvalued right now?
Based on GuruFocus' analysis, Globe Life (FRA:TMJ) is currently considered Modestly Overvalued. The stock's GF Value™ is €130.79, compared to a current price of €153.50 — trading 17.4% above its estimated fair value. The current Research & Development is €0 Mil. Globe Life's overall GF Score™ is 85/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Globe Life (FRA:TMJ), the current Research & Development is €0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Globe Life (FRA:TMJ) Overvalued in 2026?

Based on GuruFocus' analysis, Globe Life stock appears to be overvalued. The current stock price of €153.50 is trading 17.4% above its estimated GF Value™ of €130.79. GuruFocus considers Globe Life to be Modestly Overvalued.

Key valuation signals for FRA:TMJ:

  • Research & Development: €0 Mil
  • GF Value™: €130.79 vs. price of €153.50 (17.4% above fair value)
  • GF Score™: 85/100 with 9 warning signs

No single metric tells the full story. See the FRA:TMJ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Globe Life Business Description

Address 7677 Henneman Way, McKinney, TX, USA, 75070
Globe Life Inc is an insurance holding company. It provides a variety of life and supplemental health insurance products and annuities to a broad base of customers. The company's core operations are organized into three reportable segments: life insurance, supplemental health insurance and investments. Investment activities, conducted by the investment segment, focus on seeking investments with a yield and term appropriate to support the insurance product obligations. These investments generally consist of fixed maturities and, over the long term, the expected yields are considered when setting insurance premium rates and product profitability expectations.
85GF Score

Get the complete analysis for FRA:TMJ

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€153.50
Price
€130.79
GF Value